Vaccinex Inc. (NASDAQ:VCNX) traded at a new 52-week high today of $9.56. Approximately 24.3 million shares have changed hands today, as compared to an average 30-day volume of 733,000 shares.
In the past 52 weeks, shares of Vaccinex Inc. have traded between a low of $1.63 and a high of $9.56 and is now at $6.25, which is 283% above that low price.
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s product pipeline includes pepinemab (VX15) Neurology, VX5 Autoimmune, and others.
Vaccinex Inc. (NASDAQ:VCNX) is currently priced 28.0% above its average consensus analyst price target of $4.50.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer